Upgrade to SI Premium - Free Trial

Guggenheim Upgrades Editas Medicine (EDIT) to Buy

September 23, 2026 6:05 AM
(Updated - September 23, 2026 6:24 AM EDT)

Guggenheim analyst Debjit Chattopadhyay upgraded Editas Medicine (NASDAQ: EDIT) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot Upgrades Upgrades